These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 15581059)
21. AIDS-related lymphoma in Brazil. Histopathology, immunophenotype, and association with Epstein-Barr virus. Bacchi CE; Bacchi MM; Rabenhorst SH; Soares FA; Fonseca LE; Barbosa HS; Weiss LM; Gown AM Am J Clin Pathol; 1996 Feb; 105(2):230-7. PubMed ID: 8607450 [TBL] [Abstract][Full Text] [Related]
22. GI-lymphomas in immunosuppressed patients (organ transplantation; HIV). Heise W Best Pract Res Clin Gastroenterol; 2010 Feb; 24(1):57-69. PubMed ID: 20206109 [TBL] [Abstract][Full Text] [Related]
23. HIV-Related Lymphoproliferative Diseases in the Era of Combination Antiretroviral Therapy. Castelli R; Schiavon R; Preti C; Ferraris L Cardiovasc Hematol Disord Drug Targets; 2020; 20(3):175-180. PubMed ID: 32294049 [TBL] [Abstract][Full Text] [Related]
24. Highly active antiretroviral therapy and human immunodeficiency virus-associated primary cerebral lymphoma. Bower M; Powles T; Nelson M; Mandalia S; Gazzard B; Stebbing J J Natl Cancer Inst; 2006 Aug; 98(15):1088-91. PubMed ID: 16882946 [TBL] [Abstract][Full Text] [Related]
25. AIDS and non-Hodgkin's lymphoma. Experience at an oncological center in Mexico. Cornejo-Juárez P; Volkow-Fernández P; Avilés-Salas A; Calderón-Flores E Rev Invest Clin; 2008; 60(5):375-81. PubMed ID: 19227434 [TBL] [Abstract][Full Text] [Related]
26. AIDS-Associated Malignancies. Vangipuram R; Tyring SK Cancer Treat Res; 2019; 177():1-21. PubMed ID: 30523619 [TBL] [Abstract][Full Text] [Related]
27. Assessing the impact of HAART on the incidence of defining and non-defining AIDS cancers among patients with HIV/AIDS: a systematic review. Cobucci RN; Lima PH; de Souza PC; Costa VV; Cornetta Mda C; Fernandes JV; Gonçalves AK J Infect Public Health; 2015; 8(1):1-10. PubMed ID: 25294086 [TBL] [Abstract][Full Text] [Related]
28. Changing incidence and prognostic factors of survival in AIDS-related non-Hodgkin's lymphoma in the era of highly active antiretroviral therapy (HAART). Wolf T; Brodt HR; Fichtlscherer S; Mantzsch K; Hoelzer D; Helm EB; Mitrou PS; Chow KU Leuk Lymphoma; 2005 Feb; 46(2):207-15. PubMed ID: 15621803 [TBL] [Abstract][Full Text] [Related]
29. Decrease in the frequency of meningeal involvement in AIDS-related systemic lymphoma in patients receiving HAART. Navarro JT; Vall-Llovera F; Mate JL; Morgades M; Feliu E; Ribera JM Haematologica; 2008 Jan; 93(1):149-50. PubMed ID: 18166804 [TBL] [Abstract][Full Text] [Related]
30. Plasmablastic lymphoma is treatable in the HAART era. A 10 year retrospective by the AIDS Malignancy Consortium. Noy A; Lensing SY; Moore PC; Gupta N; Aboulafia D; Ambinder R; Baiocchi R; Dezube BJ; Henry D; Kaplan L; Levine AM; Mitsuyasu R; Ratner L; Reid E; Remick S; Sparano J; Tzachanis D; Wachsman W; Chadburn A Leuk Lymphoma; 2016 Jul; 57(7):1731-4. PubMed ID: 26674561 [No Abstract] [Full Text] [Related]
31. Malignancy-related causes of death in human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy. Bonnet F; Lewden C; May T; Heripret L; Jougla E; Bevilacqua S; Costagliola D; Salmon D; Chêne G; Morlat P Cancer; 2004 Jul; 101(2):317-24. PubMed ID: 15241829 [TBL] [Abstract][Full Text] [Related]
33. Therapeutic approaches to AIDS-related malignancies. Berretta M; Cinelli R; Martellotta F; Spina M; Vaccher E; Tirelli U Oncogene; 2003 Sep; 22(42):6646-59. PubMed ID: 14528290 [TBL] [Abstract][Full Text] [Related]
34. Regression of large B-cell non-Hodgkin's lymphoma of stomach with HAART: case report and review. Khan F; Bauer F; Gazi G; Bilgrami S Leuk Lymphoma; 2006 Apr; 47(4):750-4. PubMed ID: 16886274 [No Abstract] [Full Text] [Related]
35. Influence of highly active anti-retroviral therapy on response to treatment and survival in patients with acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma treated with cyclophosphamide, hydroxydoxorubicin, vincristine and prednisone. Navarro JT; Ribera JM; Oriol A; Vaquero M; Romeu J; Batlle M; Flores A; Millá F; Feliu E Br J Haematol; 2001 Mar; 112(4):909-15. PubMed ID: 11298585 [TBL] [Abstract][Full Text] [Related]
36. Human immunodeficiency virus-associated lymphomas in the antiretroviral therapy era: Analysis of the National Cancer Data Base. Olszewski AJ; Fallah J; Castillo JJ Cancer; 2016 Sep; 122(17):2689-97. PubMed ID: 27337679 [TBL] [Abstract][Full Text] [Related]
37. Results of treatment with doxorubicin, bleomycin, vinblastine and dacarbazine and highly active antiretroviral therapy in advanced stage, human immunodeficiency virus-related Hodgkin's lymphoma. Xicoy B; Ribera JM; Miralles P; Berenguer J; Rubio R; Mahillo B; Valencia ME; Abella E; López-Guillermo A; Sureda A; Morgades M; Navarro JT; Esteban H; ; Haematologica; 2007 Feb; 92(2):191-8. PubMed ID: 17296568 [TBL] [Abstract][Full Text] [Related]
38. Clinical features and predictors of survival of AIDS-related non-Hodgkin's lymphoma in a population-based case series in Sydney, Australia. Robotin MC; Law MG; Milliken S; Goldstein D; Garsia RJ; Dolan GM; Kaldor JM; Grulich AE HIV Med; 2004 Sep; 5(5):377-84. PubMed ID: 15369514 [TBL] [Abstract][Full Text] [Related]
39. AIDS-related Burkitt's lymphoma versus diffuse large-cell lymphoma in the pre-highly active antiretroviral therapy (HAART) and HAART eras: significant differences in survival with standard chemotherapy. Lim ST; Karim R; Nathwani BN; Tulpule A; Espina B; Levine AM J Clin Oncol; 2005 Jul; 23(19):4430-8. PubMed ID: 15883411 [TBL] [Abstract][Full Text] [Related]